927
Views
5
CrossRef citations to date
0
Altmetric
Review

Targeting GSK3 signaling as a potential therapy of neurodegenerative diseases and aging

, , , , , , , & show all
Pages 833-848 | Received 08 Jul 2018, Accepted 18 Sep 2018, Published online: 26 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Shivani Chandel, Rajveer Singh, Anupam Gautam & Velayutham Ravichandiran. (2022) Screening of Azadirachta indica phytoconstituents as GSK-3β inhibitor and its implication in neuroblastoma: molecular docking, molecular dynamics, MM-PBSA binding energy, and in-vitro study. Journal of Biomolecular Structure and Dynamics 40:23, pages 12827-12840.
Read now
Serena Montanari, Claudia Seidl, Lara Davani, Eleonora Gianquinto, Eliska Emrichova, Cristina Terenzi, Vincenza Andrisano & Angela De Simone. (2022) Natural products as novel scaffolds for the design of glycogen synthase kinase 3β inhibitors. Expert Opinion on Drug Discovery 17:4, pages 377-396.
Read now
Chenglei Su, Ningjun Zhao, Jianjiao Zou & Xianliang Yan. (2020) TDZD-8 alleviates delayed neurological sequelae following acute carbon monoxide poisoning involving tau protein phosphorylation. Inhalation Toxicology 32:2, pages 79-85.
Read now
Xudong Yan, Zhiyuan Li, Hong Li, Pei Liu, Zehang Zhao, Shan Cheng, Zhenlin Wang & Qiuhang Zhang. (2019) Inhibition Of Glycogen Synthase Kinase 3 Beta Suppresses The Growth And Survival Of Skull Base Chordoma Cells By Downregulating Brachyury Expression. OncoTargets and Therapy 12, pages 9783-9791.
Read now
Pei Shang, Ying Zhang, Di Ma, Yulei Hao, Xinyu Wang, Meiying Xin, Yunhai Zhang, Mingqin Zhu & Jiachun Feng. (2019) Inflammation resolution and specialized pro-resolving lipid mediators in CNS diseases. Expert Opinion on Therapeutic Targets 23:11, pages 967-986.
Read now

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.